Close

UPDATE: Berenberg Starts BioXcel Therapeutics (BTAI) at Buy

April 9, 2021 6:45 AM EDT Send to a Friend
(Updated - April 9, 2021 7:04 AM EDT)

Berenberg analyst Anita Dushyanth initiates coverage on BioXcel Therapeutics (NASDAQ: BTAI) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login